Evidence map›Paper›PMID 32859213›Full record

ArticleJournal of translational medicine2020

Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer's disease.

Andrea Saul Costa, Simone Agostini, Franca Rosa Guerini, Roberta Mancuso, Mario Clerici, Janardan P Pandey

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Andrea Saul CostaIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy. acosta@dongnocchi.it.ORCID 0000-0002-7353-157X
Simone AgostiniIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Franca Rosa GueriniIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Roberta MancusoIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Mario ClericiIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Janardan P PandeyDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Don Carlo Gnocchi Foundation · ITMedical University of South Carolina · USUniversity of Milan · IT

Funding

Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer DiseaseR21AG058489 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PANDEY, JANARDAN P · 2017 to 2018
$575k
NIA NIH HHS R21 AG058489
6 · The paper itself

Abstract

backgroundAlzheimer's Disease (AD) is a chronic neurodegenerative disorder characterized by extracellular plaques, intracellular neurofibrillary tangles and neuronal loss in the central nervous system (CNS). Pathogens are suspected to have a role in the development of AD; herpes simplex virus type 1 (HSV-1), in particular, is suggested to be a risk factor for the disease. The gamma receptor for the Fc portion of IgG molecules (FCGRs) plays a crucial role in regulating immune responses, and among FCGRs, FCGRIIB is endowed with an inhibitory function. Notably, the rs1050501 polymorphism of FCGRIIB gene associates with autoimmune diseases and with neuronal uptake and interneuronal accumulation of amyloid beta in animal AD models.

methodsGenotype and allelic distribution of ApoE4 and FCGRIIB rs1050501 were evaluated in a case-control population of 225 AD patients, 93 MCI individuals and 201 sex and age matched healthy controls (HC). HSV-1 total IgG titers and IgG subclasses were detected and quantified in a subgroup of the main study population by ELISA.

resultsGenotype and allelic distribution of FCGRIIB was comparable in the study population. HSV-1-specific antibody titers were significantly higher in AD and MCI compared to HC (p < 0.01 for both); IgG3 titers, in particular, were increased in MCI compared to AD (p = 0.04). Analyses of possible correlations between the FCGRIIB rs1050501 genotype polymorphism and IgG subclasses showed that the presence of IgG3 was more frequent in MCI carrying the FCGRIIB TT (94.1%) compared to those carrying the CT genotype (63.6%) (p = 0.03).

conclusionResults herein show an association between humoral immune response against HSV-1 and FCGRIIB rs1050501 genetic variation in the first stage of the disease.

Indexed as

Alzheimer DiseaseHerpesvirus 1, HumanAmyloid beta-PeptidesAnimalsAntibodies, ViralHumansImmunoglobulin GAmyloid beta-PeptidesAntibodies, ViralImmunoglobulin GAlzheimer’s DiseaseFCGRIIBHerpes Simplex Virus Type 1 (HSV-1)IgGsMild Cognitive ImpairmentRehabilitation

Identifiers

PMID32859213
PMCPMC7455989
OpenAlexW3082019784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.